Aurinia (NASDAQ: AUPH) officer to sell 47,000 shares for taxes

Rhea-AI Filing Summary

Aurinia Pharmaceuticals Inc. (AUPH) has a notice from officer Stephen P. Robertson indicating an intention under Rule 144 to sell up to 47,000 common shares through Morgan Stanley Smith Barney LLC on or after 08/21/2026 on NASDAQ. The shares relate to the vesting of performance stock units and are expected to be sold to satisfy associated tax withholding obligations.

Key Figures

Shares to be sold: 47,000 shares of common stock Proposed sale date: 08/21/2026 Date of Notice: 08/21/2026

3 metrics

Shares to be sold 47,000 shares of common stock Number of Aurinia Pharmaceuticals Inc. shares covered by the Rule 144 notice

Proposed sale date 08/21/2026 Proposed date of sale for the 47,000 common shares

Date of Notice 08/21/2026 Date on which the Rule 144 notice was signed by Stephen P. Robertson

Key Terms

Rule 144, performance stock units, tax withholding obligations

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

performance stock units financial

"Represents shares to be sold to satisfy tax withholding obligations upon the vesting of performance stock units."

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

tax withholding obligations financial

"Represents shares to be sold to satisfy tax withholding obligations upon the vesting of performance stock units."

FAQ

What does the Form 144 filing disclose for Aurinia Pharmaceuticals Inc. (AUPH)?

The filing states that officer Stephen P. Robertson may sell up to 47,000 Aurinia Pharmaceuticals Inc. common shares under Rule 144, with the proposed sale date of 08/21/2026 and execution through Morgan Stanley Smith Barney LLC on NASDAQ.

How many Aurinia (AUPH) shares are covered by Stephen P. Robertson’s Form 144?

The notice covers up to 47,000 common shares of Aurinia Pharmaceuticals Inc. This amount appears both in the securities information and the securities-to-be-sold sections as the number of shares proposed for sale.

What is the purpose of the planned share sale disclosed for AUPH?

The remarks state that the 47,000 shares are to be sold to satisfy tax withholding obligations arising upon the vesting of performance stock units held by officer Stephen P. Robertson.

When is the proposed sale date for the Aurinia (AUPH) shares under this Form 144?

The filing lists a proposed sale date of 08/21/2026 for the 47,000 common shares of Aurinia Pharmaceuticals Inc., and the same date appears in the securities-to-be-sold section tied to the performance stock units.

Which broker is named for executing the planned Aurinia (AUPH) Rule 144 sale?

The broker identified is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York. The filing associates this broker with the planned sale of 47,000 Aurinia common shares on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 08:55 PM Accepted by SEC EDGAR 08/21/2026 - 08:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001837798
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aurinia Pharmaceuticals Inc.
SEC File Number	001-36421
Address of Issuer	#140, 14315 - 118 Avenue Edmonton ALBERTA, CANADA T5L 4S6
Phone	250-744-2487
Name of Person for Whose Account the Securities are To Be Sold	Stephen P. Robertson
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47000	719100	133051168	08/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/21/2026	Performance Stock Units	Issuer			47000	08/21/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Represents shares to be sold to satisfy tax withholding obligations upon the vesting of performance stock units.
Date of Notice	08/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Stephen P. Robertson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)